Tag: Blood Cancers
Search News
Cells’ recycling system plays a surprising role in shaping immune cells DNA
2nd July 2025
Researchers have discovered a new mechanism by which B cells – antibody-producing immune cells – use a cellular recycling process called autophagy to control changes to their DNA essential for antibody improvement. The findings could have future implications for the development of certain blood cancers and autoimmune diseases.
Read more
Shining a Spotlight on AI Research at the Barts Cancer Institute
16th December 2024
We explore Nobel-Prize-winning research and the theory behind AI, and speak with Dr Vivek Singh, Dr Oscar Maiques and Professor Claude Chelala, three researchers using cutting-edge AI in their work at the BCI.
Read more
Scientists uncover promising leukaemia treatment targeting fat metabolism
17th October 2024
Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.
Read more
Blood Cancer Awareness Month: how can we personalise treatments to improve care?
30th September 2024
For Blood Cancer Awareness Month, Dr Lou Herman reflects on the current challenges facing blood cancer patients and how we’re addressing them.
Read more
Scientists uncover a promising strategy to combat leukaemia resistance
18th May 2023
Research reveals a vulnerability in leukaemia cells that causes them to fill with toxic fatty acids
Read more
Vitamin B5 could improve red blood cell production in people with myelodysplastic syndromes
2nd March 2023
Scientists from Barts Cancer Institute at Queen Mary University of London and the Francis Crick Institute, have uncovered why patients with a rare type of blood cancer suffer from ineffective red blood cell production, and how vitamin B5 could be combined with existing drugs to improve outcomes.
Read more